Promising effects of neurorestorative diets on motor, cognitive, and gastrointestinal dysfunction after symptom development in a mouse model of Parkinson's disease

Frontiers in Aging Neuroscience

Volumn 9, Issue MAR, 2017, Pages

  Perez Pardo, Paula ^a   de Jong, Esther M ^a   Broersen, Laus M ^a,b   Wijk, Nick van ^b   Attali, Amos ^b   Garssen, Johan ^a,b   Kraneveld, Aletta D ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b DANONE NUTRICIA RESEARCH   (Netherlands)

Author keywords

Docosahexaenoic acid; Motor symptoms; Non motor symptoms; Rotenone Parkinson's model; Uridine

Indexed keywords

DOCOSAHEXAENOIC ACID; PREBIOTIC AGENT; ROTENONE; URIDINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DIETARY INTAKE; DIGESTIVE SYSTEM FUNCTION DISORDER; INTESTINE FUNCTION; LIMIT OF QUANTITATION; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PARKINSON DISEASE; PHOSPHOLIPID SYNTHESIS; SPATIAL MEMORY; TASK PERFORMANCE;

EID: 85017246036     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2017.00057     Document Type: Article

References (53)

1. Aarsland, D., Andersen, K., Larsen, J. P., Lolk, A., and Kragh-Sørensen, P. (2003). Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch. Neurol. 60, 387-392. doi: 10.1001/archneur.60.3.387
2. Albin, R. L., Young, A. B., and Penney, J. B. (1989). The functional anatomy of basal ganglia disorders. Trends Neurosci. 12, 366-375. doi: 10.1016/0166-2236(89)90074-X
3. Boller, F., Passafiume, D., Keefe, N. C., Rogers, K., Morrow, L., and Kim, Y. (1984). Visuospatial impairment in Parkinson's disease. role of perceptual and motor factors. Arch. Neurol. 41, 485-490. doi: 10.1001/archneur.1984.04050170031011
4. Broersen, L. M., Kuipers, A. A. M., Balvers, M., van Wijk, N., Savelkoul, P. J. M., de Wilde, M. C., et al. (2013). A specific multi-nutrient diet reduces Alzheimer-like pathology in young adult AβPPswe/PS1dE9 mice. J. Alzheimers Dis. 33, 177-190. doi: 10.3233/JAD-2012-112039
5. Cansev, M., Ulus, I. H., Wang, L., Maher, T. J., and Wurtman, R. J. (2008). Restorative effects of uridine plus docosahexaenoic acid in a rat model of Parkinson's disease. Neurosci. Res. 62, 206-209. doi: 10.1016/j.neures.2008.07.005
6. Chaudhuri, K. R., and Schapira, A. H. V. (2009). Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol. 8, 464-474. doi: 10.1016/S1474-4422(09)70068-7
7. Clairembault, T., Kamphuis, W., Leclair-Visonneau, L., Rolli-Derkinderen, M., Coron, E., Neunlist, M., et al. (2014). Enteric GFAP expression and phosphorylation in Parkinson's disease. J. Neurochem. 130, 805-815. doi: 10.1111/jnc.12742
8. Clemente, J. C., Ursell, L. K., Parfrey, L. W., and Knight, R. (2012). The impact of the gut microbiota on human health: an integrative view. Cell 148, 1258-1270. doi: 10.1016/j.cell.2012.01.035
9. Crossman, A. R. (1989). Neural mechanisms in disorders of movement. Comp. Biochem. Physiol. A 93, 141-149. doi: 10.1016/0300-9629(89)90201-6
10. Cryan, J. F., and Dinan, T. G. (2015). More than a gut feeling: the microbiota regulates neurodevelopment and behavior. Neuropsychopharmacology 40, 241-242. doi: 10.1038/npp.2014.224
11. Cummings, J. L. (2012). Food for thought: Souvenaid in mild Alzheimer's disease. J. Alzheimers Dis. 31, 237-238. doi: 10.3233/JAD-2012-120245.
12. Cummings, J., Scheltens, P., McKeith, I., Blesa, R., Harrison, J. E., Bertolucci, P. H. F., et al. (2017). Effect Size analyses of souvenaid in patients with Alzheimer's Disease. J. Alzheimers Dis. 55, 1131-1139. doi: 10.3233/JAD-160745
13. Deacon, R. M. J. (2013). Measuring the strength of mice. J. Vis. Exp. 76:2610 doi: 10.3791/2610
14. de Kivit, S., Kraneveld, A. D., Garssen, J., and Willemsen, L. E. M. (2011). Glycan recognition at the interface of the intestinal immune system: target for immune modulation via dietary components. Eur. J. Pharmacol. 668(Suppl. 1), S124-S132. doi: 10.1016/j.ejphar.2011.05.086
15. de Kivit, S., Kraneveld, A. D., Knippels, L. M. J., van Kooyk, Y., Garssen, J., and Willemsen, L. E. M. (2013). Intestinal epithelium-derived galectin-9 is involved in the immunomodulating effects of nondigestible oligosaccharides. J. Innate Immun. 5, 625-638. doi: 10.1159/000350515
16. De Leonibus, E., Pascucci, T., Lopez, S., Oliverio, A., Amalric, M., and Mele, A. (2007). Spatial deficits in a mouse model of Parkinson disease. Psychopharmacology 194, 517-525. doi: 10.1007/s00213-007-0862-4
17. de Rijk, M. C., Launer, L. J., Berger, K., Breteler, M. M., Dartigues, J. F., Baldereschi, M., et al. (2000). Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54, S21-S23. doi: 10.1212/WNL.54.11.21A
18. de Waal, H., Stam, C. J., Lansbergen, M. M., Wieggers, R. L., Kamphuis, P. J. G. H., Scheltens, P., et al. (2014). The effect of souvenaid on functional brain network organisation in patients with mild Alzheimer's disease: a randomised controlled study. PLoS ONE 9:e86558. doi: 10.1371/journal.pone.0086558
19. Fasano, A., Visanji, N. P., Liu, L. W. C., Lang, A. E., and Pfeiffer, R. F. (2015). Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol. 14, 625-639. doi: 10.1016/S1474-4422(15)00007-1
20. Giraudo, M. D., Gayraud, D., and Habib, M. (1997). Visuospatial ability of parkinsonians and elderly adults in location memory tasks. Brain Cogn. 34, 259-273. doi: 10.1006/brcg.1997.0898
21. Inden, M., Kitamura, Y., Takeuchi, H., Yanagida, T., Takata, K., Kobayashi, Y., et al. (2007). Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone. J. Neurochem. 101, 1491-1504. doi: 10.1111/j.1471-4159.2006.04440.x
22. Janickova, H., Rudajev, V., Dolejsi, E., Koivisto, H., Jakubik, J., Tanila, H., et al. (2015). Lipid-Based diets improve muscarinic neurotransmission in the hippocampus of transgenic APPswe/PS1dE9 Mice. Curr. Alzheimer Res. 12, 923-931. doi: 10.2174/1567205012666151027130350
23. Jansen, D., Zerbi, V., Arnoldussen, I. A. C., Wiesmann, M., Rijpma, A., Fang, X. T., et al. (2013). Effects of specific multi-nutrient enriched diets on cerebral metabolism, cognition and neuropathology in AβPPswe-PS1dE9 mice. PLoS ONE 8:e75393. doi: 10.1371/journal.pone.0075393
24. Jeurink, P. V., van Esch, B. C. A. M., Rijnierse, A., Garssen, J., and Knippels, L. M. J. (2013). Mechanisms underlying immune effects of dietary oligosaccharides. Am. J. Clin. Nutr. 98, 572S-577S. doi: 10.3945/ajcn.112.038596
25. Lee, H. M., and Koh, S.-B. (2015). Many Faces of Parkinson's disease: non-motor symptoms of Parkinson's disease. J. Mov. Disord. 8, 92-97. doi: 10.14802/jmd.15003
26. Leiter, J. R. S., Peeler, J., and Anderson, J. E. (2011). Exercise-induced muscle growth is muscle-specific and age-dependent. Muscle Nerve 43, 828-838. doi: 10.1002/mus.21965
27. Martinez-Martin, P., Rodriguez-Blazquez, C., Kurtis, M. M., and Chaudhuri, K. R., and NMSS Validation Group (2011). The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease. Mov. Disord. 26, 399-406. doi: 10.1002/mds.23462
28. Maslowski, K. M., and Mackay, C. R. (2011). Diet, gut microbiota and immune responses. Nat. Immunol. 12, 5-9. doi: 10.1038/ni0111-5
29. Meksawan, K., Chaotrakul, C., Leeaphorn, N., Gonlchanvit, S., Eiam-Ong, S., and Kanjanabuch, T. (2016). Effects of fructo-oligosaccharide supplementation on constipation in elderly continuous ambulatory peritoneal dialysis patients. Perit. Dial. Int. 36, 60-66. doi: 10.3747/pdi.2014.00015
30. Müller, B., Assmus, J., Herlofson, K., Larsen, J. P., and Tysnes, O.-B. (2013). Importance of motor vs. non-motor symptoms for health-related quality of life in early parkinson's disease. Parkinsonism Relat. Disord. 19, 1027-1032. doi: 10.1016/j.parkreldis.2013.07.010
31. Nussbaum, R. L., and Ellis, C. E. (2003). Alzheimer's disease and Parkinson's disease. N. Engl. J. Med. 348, 1356-1364. doi: 10.1056/NEJM2003ra020003
32. Pallier, P. N., Poddighe, L., Zbarsky, V., Kostusiak, M., Choudhury, R., Hart, T., et al. (2015). A nutrient combination designed to enhance synapse formation and function improves outcome in experimental spinal cord injury. Neurobiol. Dis. 82, 504-515. doi: 10.1016/j.nbd.2015.09.007
33. Pardini, M., Serrati, C., Guida, S., Mattei, C., Abate, L., Massucco, D., et al. (2015). Souvenaid reduces behavioral deficits and improves social cognition skills in frontotemporal dementia: a proof-of-concept study. Neurodegener. Dis. 15, 58-62. doi: 10.1159/000369811
34. Perez-Pardo, P., Dodiya, H. B., Broersen, L. M., Douna, H., van Wijk, N., Lopes de Silva, S., et al. (2017). Gut-brain brain-gut axis in Parkinson's disease models: effects of a uridine fish oil diet. Nutr. Neurosci. 1-12. doi: 10.1080/1028415X.2017.1294555. [Epub ahead of print].
35. Pfeiffer, R. F. (2011). Gastrointestinal dysfunction in Parkinson's disease. Parkinsonism Relat. Disord. 17, 10-15. doi: 10.1016/j.parkreldis.2010.08.003
36. Poewe, W., Antonini, A., Zijlmans, J. C., Burkhard, P. R., and Vingerhoets, F. (2010). Levodopa in the treatment of Parkinson's disease: an old drug still going strong. Clin. Interv. Aging 5, 229-238. doi: 10.2147/CIA.S6456
37. Rasmussen, H., Piazza, B., Forsyth, C., and Keshavarzian, A. (2014). "Nutrition and gastrointestinal health as modulators of Parkinson's Disease, " in Pharma-Nutrition AAPS Advances in the Pharmaceutical Sciences Series, eds G. Folkerts and J. Garssen (Springer International Publishing), 213-242.
38. Reeves, P. G., Nielsen, F. H., and Fahey, G. C. (1993). AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123, 1939-1951.
39. Sakamoto, T., Cansev, M., and Wurtman, R. J. (2007). Oral supplementation with docosahexaenoic acid and uridine-5'-monophosphate increases dendritic spine density in adult gerbil hippocampus. Brain Res. 1182, 50-59. doi: 10.1016/j.brainres.2007.08.089
40. Savelkoul, P. J. M., Janickova, H., Kuipers, A. A. M., Hageman, R. J. J., Kamphuis, P. J., Dolezal, V., et al. (2012). A specific multi-nutrient formulation enhances M1 muscarinic acetylcholine receptor responses in vitro. J. Neurochem. 120, 631-640. doi: 10.1111/j.1471-4159.2011.07616.x
41. Scheltens, P., Twisk, J. W. R., Blesa, R., Scarpini, E., von Arnim, C. A. F., Bongers, A., et al. (2012). Efficacy of souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. J. Alzheimers Dis. 31, 225-236. doi: 10.3233/JAD-2012-121189
42. Scholtens, P. A. M. J., Goossens, D. A. M., and Staiano, A. (2014). Stool characteristics of infants receiving short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides: a review. World J. Gastroenterol. 20, 13446-13452. doi: 10.3748/wjg.v20.i37.13446
43. Schrag, A., Jahanshahi, M., and Quinn, N. (2000). How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population. Mov. Disord. 15, 1112-1118. doi: 10.1002/1531-8257(200011)15
44. Schrag, A., and Quinn, N. (2000). Dyskinesias and motor fluctuations in Parkinson's disease. a community-based study. Brain J. Neurol. 123(Pt 11), 2297-2305. doi: 10.1093/brain/123.11.2297
45. van Hoffen, E., Ruiter, B., Faber, J., M'Rabet, L., Knol, E. F., Stahl, B., et al. (2009). A specific mixture of short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides induces a beneficial immunoglobulin profile in infants at high risk for allergy. Allergy 64, 484-487. doi: 10.1111/j.1398-9995.2008.01765.x
46. van Wijk, N., Balvers, M., Cansev, M., Maher, T. J., Sijben, J. W. C., and Broersen, L. M. (2016). Dietary crude lecithin increases systemic availability of dietary docosahexaenoic acid with combined intake in rats. Lipids 51, 833-846. doi: 10.1007/s11745-016-4139-8
47. van Wijk, N., Broersen, L. M., de Wilde, M. C., Hageman, R. J. J., Groenendijk, M., Sijben, J. W. C., et al. (2014). Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination. J. Alzheimers Dis. 38, 459-479. doi: 10.3233/JAD-130998.
48. Wang, L., Pooler, A. M., Albrecht, M. A., and Wurtman, R. J. (2005). Dietary uridine-5'-monophosphate supplementation increases potassium-evoked dopamine release and promotes neurite outgrowth in aged rats. J. Mol. Neurosci. 27, 137-145. doi: 10.1385/JMN:27:1:137
49. Wiesmann, M., Zerbi, V., Jansen, D., Haast, R., Lütjohann, D., Broersen, L. M., et al. (2016). A dietary treatment improves cerebral blood flow and brain connectivity in aging apoe4 mice. Neural Plast. 2016:6846721. doi: 10.1155/2016/6846721
50. Wiesmann, M., Zinnhardt, B., Reinhardt, D., Eligehausen, S., Wachsmuth, L., Hermann, S., et al. (2017). A specific dietary intervention to restore brain structure and function after ischemic stroke. Theranostics 7, 493-512. doi: 10.7150/thno.17559
51. Wurtman, R. J., Cansev, M., Sakamoto, T., and Ulus, I. (2010). Nutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses. Nutr. Rev. 68(Suppl. 2), S88-S101. doi: 10.1111/j.1753-4887.2010.00344.x
52. Wurtman, R. J., Cansev, M., Sakamoto, T., and Ulus, I. H. (2009). Use of phosphatide precursors to promote synaptogenesis. Annu. Rev. Nutr. 29, 59-87. doi: 10.1146/annurev-nutr-080508-141059
53. Zerbi, V., Jansen, D., Wiesmann, M., Fang, X., Broersen, L. M., Veltien, A., et al. (2014). Multinutrient diets improve cerebral perfusion and neuroprotection in a murine model of Alzheimer's disease. Neurobiol. Aging 35, 600-613. doi: 10.1016/j.neurobiolaging.2013.09.038